| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 11 Aug 2025 | 14 Jul 2025 |
| AGM 11/08/2025 Intimation of the Forty-Third Annual General Meeting of the Company and Record Date for payment of Dividend. Intimation of Record Date for payment of final Dividend, if declared Notice of Forty-Third Annual General Meeting of the Company and Integrated Report for FY 2024-25. (As Per BSE Announcement Dated on: 19/07/2025) Integrated Report for FY 2024-25 - Revised. (As Per BSE Announcement Dated on :23.07.2025) Proceedings of the Forty-Third Annual General Meeting held on August 11, 2025. (As Per BSE Announcement Dated on: 11.08.2025) | ||
The inspection was held between September 8 and 16. Lupin did not disclose the details of the observations but said it would respond within the required timeline.
The launch aligns with Lupin’s strategic push into injectables, biosimilars, and inhalation therapies, supported by robust R&D and manufacturing capabilities
Here are some of the stocks that may see significant price movement today: Bharti Airtel, Torrent Power, Lupin Limited, etc.
This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated in India.
Here are some of the stocks that may see significant price movement today: Godrej Properties, SBI Cards, Hyudai India, etc.
The tablets will be made at the company’s Goa facility, a site that has previously cleared global regulatory inspections and supports Lupin’s key exports.
The company said this deal fits into its larger strategy of expanding respiratory therapies beyond its home markets.
StainCares added that partnership plans to enhance its biosimilar portfolio and back cost-effective healthcare in Latin America.
Here are some of the stocks that may see significant price movement today: Lupin, IndiGo, Nazara Tech, Aurobindo Pharma, etc.
The drug will be manufactured at Lupin's facility in Nagpur, India, and the company has announced plans for a near-term launch in the U.S. market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
